Brief: 9 Meters Biopharma Inc - Announces Initiation Of Phase 2 Vibrant Study Of Vurolenatide For Short Bowel Syndrome

9 Meters Biopharma

14/06/2021 12:44

June 14 (Reuters) - 9 Meters Biopharma Inc  NMTR.O :
    * 9 METERS BIOPHARMA INC - ANNOUNCES INITIATION OF PHASE 2
VIBRANT
STUDY OF VUROLENATIDE FOR SHORT BOWEL SYNDROME
    * 9 METERS BIOPHARMA INC - TOPLINE RESULTS OF THE
MULTICENTER
VIBRANT STUDY ANTICIPATED IN Q4 2021

Source text for Eikon: [https://bit.ly/3znohWB]
Further company coverage:  NMTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))